BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27315568)

  • 1. MAD2γ, a novel MAD2 isoform, reduces mitotic arrest and is associated with resistance in testicular germ cell tumors.
    López-Saavedra A; Ramírez-Otero M; Díaz-Chávez J; Cáceres-Gutiérrez R; Justo-Garrido M; Andonegui MA; Mendoza J; Downie-Ruíz Á; Cortés-González C; Reynoso N; Castro-Hernández C; Domínguez-Gómez G; Santibáñez M; Fabián-Morales E; Pruefer F; Luna-Maldonado F; González-Barrios R; Herrera LA
    Cell Cycle; 2016 Aug; 15(15):2066-76. PubMed ID: 27315568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells.
    Fung MK; Cheung HW; Ling MT; Cheung AL; Wong YC; Wang X
    Br J Cancer; 2006 Aug; 95(4):475-84. PubMed ID: 16880791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAD2 expression and its significance in mitotic checkpoint control in testicular germ cell tumour.
    Fung MK; Cheung HW; Wong HL; Yuen HF; Ling MT; Chan KW; Wong YC; Cheung AL; Wang X
    Biochim Biophys Acta; 2007 Jun; 1773(6):821-32. PubMed ID: 17467818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCPH expression is an early event in the development of testicular germ cell tumors.
    Regadera J; Blánquez MJ; González-Peramato P; Nistal M; Miller JC; Tirado OM; Notario V
    Int J Oncol; 2006 Mar; 28(3):595-604. PubMed ID: 16465363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells.
    Cheung HW; Jin DY; Ling MT; Wong YC; Wang Q; Tsao SW; Wang X
    Cancer Res; 2005 Feb; 65(4):1450-8. PubMed ID: 15735033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells' sensitivity to paclitaxel.
    Tambe M; Pruikkonen S; Mäki-Jouppila J; Chen P; Elgaaen BV; Straume AH; Huhtinen K; Cárpen O; Lønning PE; Davidson B; Hautaniemi S; Kallio MJ
    Oncotarget; 2016 Mar; 7(11):12267-85. PubMed ID: 26943585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
    Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
    Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of REV7 enhances chemosensitivity and overcomes acquired chemoresistance in testicular germ cell tumors.
    Sakurai Y; Ichinoe M; Yoshida K; Nakazato Y; Saito S; Satoh M; Nakada N; Sanoyama I; Umezawa A; Numata Y; Shi-Xu J; Ichihara M; Takahashi M; Murakumo Y
    Cancer Lett; 2020 Oct; 489():100-110. PubMed ID: 32553781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
    Selfe J; Goddard NC; McIntyre A; Taylor KR; Renshaw J; Popov SD; Thway K; Summersgill B; Huddart RA; Gilbert DC; Shipley JM
    J Pathol; 2018 Feb; 244(2):242-253. PubMed ID: 29160922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors.
    Cavallo F; Feldman DR; Barchi M
    Int J Dev Biol; 2013; 57(2-4):273-80. PubMed ID: 23784838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.
    Bargiela-Iparraguirre J; Prado-Marchal L; Pajuelo-Lozano N; Jiménez B; Perona R; Sánchez-Pérez I
    Cell Cycle; 2014; 13(22):3590-601. PubMed ID: 25483095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
    Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
    Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness.
    Nuti F; Luciani P; Marinari E; Erdei E; Bak M; Deledda C; Rosati F; Mazzinghi B; Danza G; Stoop H; Looijenga LH; Peri A; Serio M; Krausz C
    J Pathol; 2009 Dec; 219(4):491-500. PubMed ID: 19844922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
    Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT
    Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors.
    Schmidtova S; Kalavska K; Kucerova L
    Curr Oncol Rep; 2018 Sep; 20(11):88. PubMed ID: 30259297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity.
    Awuah SG; Riddell IA; Lippard SJ
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):950-955. PubMed ID: 28096358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiles of PIWIL2 short isoforms differ in testicular germ cell tumors of various differentiation subtypes.
    Gainetdinov IV; Skvortsova YV; Stukacheva EA; Bychenko OS; Kondratieva SA; Zinovieva MV; Azhikina TL
    PLoS One; 2014; 9(11):e112528. PubMed ID: 25384072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications.
    Kalavska K; Conteduca V; De Giorgi U; Mego M
    Curr Cancer Drug Targets; 2018; 18(10):967-978. PubMed ID: 29295694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and MDM2 expression in primary and metastatic testicular germ cell tumors: Association with clinical outcome.
    Lobo J; Alzamora MA; Guimarães R; Cantante M; Lopes P; Braga I; Maurício J; Jerónimo C; Henrique R
    Andrology; 2020 Sep; 8(5):1233-1242. PubMed ID: 32384200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and roles of system L amino acid transporters in human embryonal carcinoma cells.
    Chatsirisupachai K; Kitdumrongthum S; Panvongsa W; Janpipatkul K; Worakitchanon W; Lertjintanakit S; Wongtrakoongate P; Chairoungdua A
    Andrology; 2020 Nov; 8(6):1844-1858. PubMed ID: 32741077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.